Biochemical markers predictive for bone marrow involvement in systemic mastocytosis

Haematologica

Volumn 93, Issue 1, 2008, Pages 120-123

  Donker, Marjolein L ^a   Van Doormaal, Jasper J ^a   Van Doormaal, Frederiek F ^a   Kluin, Philip M ^a   Van Der Veer, Eveline ^a   De Monchy, Jan G R ^a   Kema, Ido P ^a   Kluin Nelemans, Hanneke C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Biochemical markers; Bone marrow involvement; Mastocytosis; N methylhistamine; N methylimidazole acetic acid; Tryptase

Indexed keywords

1 METHYLIMIDAZOLE; ACETIC ACID; BIOCHEMICAL MARKER; N METHYLHISTAMINE; TRYPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; SYSTEMIC MASTOCYTOSIS; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE MARROW; CHEMISTRY, CLINICAL; FEMALE; HUMANS; IMIDAZOLES; MALE; MASTOCYTOSIS, SYSTEMIC; METHYLHISTAMINES; MIDDLE AGED; TRYPTASES;

EID: 38549143755     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11558     Document Type: Article

References (13)

1. Pardanani A, Akin C, Valent P. Pathogenesis, clinical features, and treatment advances in mastocytosis. Best Pract Res Clin Haematol 2006;19:595-615.
2. Patnaik MM, Rindos M, Kouides PA, Tefferi A, Pardanani A. Systemic mastocytosis: a concise clinical and laboratory review. Arch Pathol Lab Med 2007;131:784-91.
3. Akin C, Metcalfe DD. Systemic mastocytosis. Annu Rev Med 2004;55:419-32.
4. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Jr., Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006;117:391-7.
5. Kors JW, Van Doormaal JJ, Breukelman H, Van Voorst Vader PC, De Monchy JG. Long-term follow-up of indolent mastocytosis in adults. J Intern Med 1996;239:157-64.
6. Granerus G, Lonnqvist B, Nystrand J, Roupe G. Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover. Br J Dermatol 1998;139:858-61.
7. Keyzer JJ, Wolthers BG, Muskiet FA, Kauffman HF, Groen A. Determination of N tau-methylhistamine in plasma and urine by isotope dilution mass fragmentography. Clin Chim Acta 1981;113:165-73.
8. Keyzer JJ, Wolthers BG, Breukelman H, Kauffman HF, de Monchy JG. Determination of N tau-methylimidazoleacetic acid (a histamine metabolite) in urine by gas chromatography using nitrogen-phosphorus detection. Clin Chim Acta 1982;121:379-87.
9. Pardanani A, Kimlinger T, Reeder T, Li CY, Tefferi A. Bone marrow mast cell immunophenotyping in adults with mast cell disease: a prospective study of 33 patients. Leuk Res 2004;28:777-83.
10. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-4.
11. Worobec AS, Semere T, Nagata H, Metcalfe DD. Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer 1998;83:2120-9.
12. Valent P, Horny HP, Li CY, Longley JB, Metcalfe DD, Parwaresch RM, et al. Mastocytosis (mast cell disease). World Health Organization (WHO) classification of tumours. Pathology and genetics. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Tumours of haematopoietic and lymphoid tissues. Vol 1. World Health Organization. Lyon, France: IARC Press, 2001;291-302.
13. Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res 2001;25:553-62.